| 4882 |
Perseus Proteomics Inc.
|
Strategy |
|
Explanation Regarding Fundraising
|
Nov 20, 2026
|
| 4443 |
Sansan, Inc.
|
Strategy |
|
Presentation Materials on Making KiteRa a Group Company
|
Nov 20, 2026
|
| 4444 |
INFONET GROUP inc.
|
M&A |
|
Supplementary Explanation Materials for the Issuance of the 3rd and 4th Stock Acquisition Rights
|
Nov 20, 2026
|
| 3988 |
SYS Holdings Co., Ltd.
|
M&A |
|
Notice Regarding Acquisition of Shares (Becoming a Wholly-Owned Subsidiary) of Takahashi Giken Co., Ltd.
|
Nov 20, 2026
|
| 9823 |
Mammy Mart Holdings Corporation
|
Strategy |
|
Mid-Term Management Plan (2027–2029) — Balancing Further Differentiation and Profitability Improvement
|
Nov 20, 2026
|
| 2334 |
eole Inc.
|
Strategy |
|
Notice of Business Collaboration with SoftBank Corp. for Reciprocal Sales of AI Data Centers and GPU Computing Resources
|
Nov 20, 2026
|
| 8977 |
Hankyu Hanshin REIT, Inc.
|
Strategy |
|
Supplementary Explanatory Materials Regarding Asset Replacement and Press Release
|
Nov 19, 2026
|
| 8960 |
United Urban Investment Corporation
|
Strategy |
|
Notice Regarding Acquisition of Domestic Trust Beneficiary Interest (Midosuji Frontier)
|
Nov 19, 2026
|
| 4918 |
Ivy Cosmetics Corporation
|
Strategy |
|
Notification Regarding Grant of Patent Following National Phase Entry of International (PCT) Application for Anti-Cancer Substance (New Compound) on November 19, 2026
|
Nov 19, 2026
|
| 6417 |
Sankyo Co., Ltd.
|
Strategy |
|
Notice Regarding Acquisition of Shares of the SUNTAC Group (Subsidiarization, etc.)
|
Nov 19, 2026
|
| 4892 |
Cyfuse Biomedical K.K.
|
Strategy |
|
Notice Regarding Progress in Development of New 3D Cellular Products and Recognition of Non-Operating Income
|
Nov 19, 2026
|
| 3168 |
MERF Inc.
|
Strategy |
|
Mid-Term Management Plan 2029 | Disclosure of Key Strategies and Financial Targets
|
Nov 19, 2026
|
| 4596 |
Kubota Pharmaceutical Holdings Co., Ltd.
|
Strategy |
|
Kubota Pharmaceutical Holdings Co., Ltd. Announcement of Start of Final Formulation Manufacturing of Emixstat Hydrochloride (Retakubo) by Consolidated Subsidiary
|
Nov 19, 2026
|
| 9214 |
Recovery International Co.,Ltd.
|
Strategy |
|
Notice Regarding Commencement of New Business
|
Nov 18, 2026
|
| 8127 |
Yamato International Inc.
|
M&A |
|
Notice of Acquisition of Shares of a Special Purpose Company (SPC) (Making Subsidiary, etc.)
|
Nov 18, 2026
|
| 3750 |
ADR Biomedical Holdings Inc.
|
Strategy |
|
Notice Regarding Commencement of a New Business
|
Nov 18, 2026
|
| 3415 |
TOKYO BASE Co.,Ltd.
|
Strategy |
|
Announcement: Accelerating Overseas Store Expansion — CONZ New York / PUBLIC TOKYO Seoul Opening in December
|
Nov 18, 2026
|
| 8616 |
Tokai Tokyo Financial Holdings, Inc.
|
Strategy |
|
Earnings / Investor Presentation Materials
|
Nov 18, 2026
|
| 3083 |
Star seeds Co.,Ltd.
|
M&A |
|
Notice of Execution of Basic Agreement on Business Alliance with Isuzu Co., Ltd. for Container-type AI Data Center Business
|
Nov 18, 2026
|
| 4892 |
Cyfuse Biomedical K.K.
|
Strategy |
|
Notice of Start of Investigator-Initiated Clinical Trial Based on Joint Research with Keio University and Fujita Health University — Development of a Novel Osteochondral Regeneration Platform Technology for Idiopathic Medial Femoral Condyle Osteonecrosis
|
Nov 18, 2026
|